Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-11-2011 | Letter to the Editor

c-Kit+ Cells Transplantation as a New Treatment for Autism, a Novel Hypothesis with Important Research and Clinical Implication

Auteur: Ahmad Ghanizadeh

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 11/2011

Excerpt

The excitatory amino acid neurotransmitter of Glutamate has a major role in the brain. However, it has a balance. Excess glutamate is neurotoxic. Glutamate transporters control the level of glutamate in synaptic space. There are different types of glutamate transporters. One of the transporters is GLT-1, which is distributed throughout different brain regions and spinal cord, and which is not present in the white matter (Maragakis and Rothstein 2001). GLT-1 has an important role for removal of glutamate (Danbolt 2001; Robinson 1998). In order to prevent excitotoxicity, these transporters keep glutamate synaptic concentrations low. …

vorige artikel Brief Report: Excellent Agreement Between Two Brief Autism Scales (Checklist for Autism Spectrum Disorder and Social Responsiveness Scale) Completed Independently by Parents and the Autism Diagnostic Interview-Revised

volgende artikel Congenital Blindness and Autism

Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22(5), 574–579.PubMedCrossRef

Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Simone, C., et al. (2010). Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Human Molecular Genetics, 19(19), 3782–3796.PubMedCrossRef

Danbolt, N. C. (2001). Glutamate uptake. Progress in Neurobiology, 65(1), 1–105.PubMedCrossRef

Ghanizadeh, A. (2010a). Transplantation of GABAergic cell line as a novel hypothesized treatment for autism. Epilepsy & Behavior, 19(4), 664.CrossRef

Ghanizadeh, A. (2010b). Targeting neurotensin as a potential novel approach for the treatment of autism. Journal of Neuroinflammation, 7, 58.PubMedCrossRef

Ghanizadeh, A. (2011). Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochemical Research. doi:10.1007/s11064-010-0381-2.

Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., et al. (2010). Non-invasive evaluation of the GABAergic/Glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. Journal of Autism and Developmental Disorders. [Epub ahead of print].

Maragakis, N. J., & Rothstein, J. D. (2001). Glutamate transporters in neurologic disease. Archives of Neurology, 58(3), 365–370.PubMedCrossRef

Niederhofer, H. (2007a). Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. Journal of Clinical Psychopharmacology, 27(3), 317–318.PubMedCrossRef

Niederhofer, H. (2007b). Treating autism pharmacologically: also tacrine might improve symptomatology in some cases. Journal of Child Neurology, 22(8), 1054; author reply 1054–1055.

Robinson, M. B. (1998). The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype. Neurochemistry International, 33(6), 479–491.PubMedCrossRef

Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 16(3), 675–686.PubMedCrossRef

Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuropsychopharmacology and Biological Psychiatry, 30(8), 1472–1477.CrossRef

Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology, 35(4), 976–989.

Titel: c-Kit+ Cells Transplantation as a New Treatment for Autism, a Novel Hypothesis with Important Research and Clinical Implication
Auteur: Ahmad Ghanizadeh
Publicatiedatum: 01-11-2011
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 11/2011
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-010-1174-9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Excerpt

Log in om toegang te krijgen

Andere artikelen Uitgave 11/2011

Diminished Sensitivity to Sad Facial Expressions in High Functioning Autism Spectrum Disorders is Associated with Symptomatology and Adaptive Functioning

Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome

Brief Report: “Allergic Symptoms” in Children with Autism Spectrum Disorders. More than Meets the Eye?

Janice E. Janzen: Autism Handbook for Parents: Facts and Strategies for Parenting Success

Music Interventions for Children with Autism: Narrative Review of the Literature

Avatar Assistant: Improving Social Skills in Students with an ASD Through a Computer-Based Intervention